FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

LondonMetric raises quarterly dividend by 7% to 3.05p

LondonMetric has declared a 7% increase in its first quarterly interim dividend for FY 2025/26 to 3.05 pence per share, payable as a Property Income Distribution. The dividend will be paid on 8 October 2025, with an ex-dividend date of 28 August 2025 and a scrip alternative available...

August 20, 2025

Convatec Group Plc launches $300m share buyback programme

Convatec has announced a non-discretionary share buyback of up to $300 million to return surplus capital to shareholders. The programme, managed by UBS AG London Branch, will run until 31 December 2025 and aims to reduce the company’s share capital, with purchased shares either cancelled or held in treasury for employee plans...

August 20, 2025

Babcock International appoints Aedamar Comiskey as Non-Executive Director

Babcock International has announced the appointment of Aedamar Comiskey as a Non-Executive Director, effective 1 September 2025. She will serve on the Nominations, Audit and Remuneration committees, bringing extensive corporate law and board experience from her leadership roles at Linklaters and James Fisher and Sons plc...

August 19, 2025

Landsec sells Queen Anne’s Mansions office block for £245m

Landsec has agreed the £245m unconditional sale of its Queen Anne’s Mansions office block in SW1 to Arora Group. The deal, which crystallises redevelopment value and delivers an immediate uplift to return on equity, marks early progress towards Landsec’s plan to release £2bn from offices by 2030...

August 18, 2025

Associated British Foods to acquire Hovis Group

Associated British Foods has agreed to acquire Hovis Group from Endless LLP, combining it with Allied Bakeries to form a more efficient and sustainable UK bread business...

August 15, 2025

Antofagasta Plc delivers 60% EBITDA growth in H1 2025

Antofagasta plc reported a 60% rise in EBITDA to $2.23 billion for the first half of 2025, with margins up 12 percentage points to 58.8% and underlying earnings per share more than doubling to 47.4 cents...

August 14, 2025

National Grid Plc to sell Grain LNG for £1.66 billion

National Grid plc has agreed to sell its Grain LNG business to a consortium comprising Centrica plc and Energy Capital Partners LLC for approximately £1.66 billion, including a pre-completion dividend...

August 14, 2025

Diploma Plc CFO resigns over conduct

Diploma PLC announced the immediate resignation of Chief Financial Officer Chris Davies following a lapse in personal conduct at a recent company event. The decision is unrelated to financial performance, and FY25 guidance remains unchanged...

August 14, 2025

Unite Group to acquire Empiric in £723 million cash and share deal

Unite Group has agreed to acquire Empiric Student Property plc in a recommended cash and share offer valuing the company at approximately £723 million, including dividends. The deal will create a £10.5 billion UK student accommodation portfolio...

August 14, 2025

Entain H1 2025 results beat expectations, FY guidance upgraded

Entain plc reported a 7% rise in total group net gaming revenue for H1 2025, including a 35% constant currency increase from BetMGM. Online performance exceeded forecasts, with UK & Ireland up 21% and Brazil up 21%...

August 12, 2025

Spirax Group Plc reports organic growth and dividend increase in H1 results

Spirax Group reported half-year revenue of £822.2m, down 1% reported but up 3% organically, with adjusted operating profit rising 7% organically to £158.8m. Statutory profit was affected by restructuring costs and currency headwinds, while adjusted cash conversion improved to 61%...

August 12, 2025

GSK’s Gepotidacin receives US FDA Priority Review for gonorrhoea treatment

GSK has announced that the US FDA has accepted for priority review a supplemental New Drug Application for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea in patients aged 12 and over...

August 11, 2025

GSK to receive $370m settlement and royalties from mRNA patent agreement

GSK will receive a $370 million upfront payment, plus 1% royalties on US sales of certain mRNA vaccines by BioNTech and Pfizer, following a settlement linked to CureVac’s recent agreement with BioNTech...

August 8, 2025

Hikma Pharmaceuticals reports 6% revenue growth and confirms FY outlook

Hikma Pharmaceuticals posted a 6% rise in H1 2025 revenue to $1.66 billion, supported by strong Injectables and Branded sales. Core operating profit declined 7% due to product mix and prior-year comparators, but the company expects a stronger H2...

August 7, 2025

Hiscox Ltd reports profitable growth across all divisions in H1 2025

Hiscox delivered 5.7% growth in written premiums to $2.94bn and maintained strong profitability with a 92.6% combined ratio. Retail margins expanded, investment income rose to $234.9m, and operating return on tangible equity reached 14.5%...

August 6, 2025

Legal & General grows core EPS by 9% as strategic focus strengthens

Legal & General reported a 9% rise in core operating EPS and a 6% increase in core operating profit to £859m for H1 2025. The group recorded £5.2bn of new Institutional Retirement business and grew Workplace pension assets to over £100bn...

August 6, 2025

Coca-Cola HBC reports 9.9% organic revenue growth in H1 2025

Coca-Cola HBC delivered 9.9% organic revenue growth and a 15.2% rise in reported EBIT to €649.8m for H1 2025, driven by strong performance in Emerging markets, pricing initiatives, and innovation across its 24/7 portfolio...

August 6, 2025

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company also announced a $500m share buyback for H2, supported by strong cash generation and margin expansion...

August 5, 2025

Diageo Plc FY25 profit down 28%, free cash flow rises to $2.7bn

Diageo reported FY25 operating profit of $4.3bn, down 27.8%, impacted by exceptional costs and currency headwinds. Organic net sales rose 1.7%, while free cash flow increased to $2.7bn. The group raised its cost savings target to $625m and reaffirmed its outlook for mid-single-digit profit growth in FY26...

August 5, 2025

BP Plc reports $2.4bn Q2 underlying profit, launches $750m buyback

BP delivered a $2.4bn underlying replacement cost profit in Q2 2025, supported by strong trading and refining margins. Operating cash flow reached $6.3bn, and net debt fell to $26.0bn. The company declared a dividend of 8.32 cents per share and announced a $750m share buyback...

August 5, 2025

Funds

November 20, 2018